increased pain in RA flareups; Brainfog; anxiety; sleep deprivation; shortness of memory; stiff and burning sensation in joints; stiff and burning sensation in joints; mouth sores; moving slower much slower; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955), first dose via an unspecified route of administration, administered in Arm Left on 20Mar2021 (reported as 10:30) (at the age of 59 years old, not pregnant), single dose for covid-19 immunization. Medical history included rheumatoid arthritis, fibromyalgia, known allergies: Sulfa and tetracycline, from an unknown date. Concomitant medications included hydroxychloroquine; indometacin sodium (INDOCIN); methotrexate. On 20Mar2021, patient experienced Brainfog, anxiety, sleep deprivation, shortness of memory, increased pain in RA flareups, stiff and burning sensation in joints, mouth sores,moving slower much slower. The outcome of the events was not recovered. No treatment for the adverse events. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  Information related to batch/Lot no. was requested.